- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02019836
Comparison of Maternal and Neonatal Vitamin D Levels in Term Neonates With and Without Early Onset Sepsis
December 26, 2013 updated by: Merih Cetinkaya, Kanuni Sultan Suleyman Training and Research Hospital
Neonatal sepsis is a clinical syndrome characterized by signs and symptoms of infection with or without accompanying bacteremia in the first month of life which is still an important cause of morbidity and mortality.
Vitamin D is a fat-soluble steroid hormone that primarily contributes to the maintenance of normal calcium homeostasis and skeletal mineralization.
In addition to its classical role in bone metabolism, vitamin D also has immunomodulatory effects on immune function.
Although some studies reported a link between vitamin D deficiency and critical illness in adults, a direct relationship has not been directly shown yet.
However, to the best of our knowledge, no study evaluated the association between EOS and maternal/neonatal vitamin D levels.
The objective of this prospective study is to determine the possible role of maternal and neonatal plasma vitamin D levels on EOS development in term infants.
We also aim to evaluate possible effect of the severity of vitamin D deficiency on EOS development in the study population.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Term infants with clinical and laboratory findings of early onset sepsis who are >37 weeks of gestational age and will be admitted to Neonatal Care Unit of Kanuni Sultan Suleyman Training and Research Hospital will be included in this prospective study.
The study group will consist of term neonates who are clinically suspected to have an early infection from the 1st day of life.
Blood for neonatal and maternal vitamin D levels will be obtained from all infants and their mothers at the time of hospital admission.
Only infants with high probable sepsis will consist the study group.
The healthy infants who admit to our outpatient clinic for routine evaluation at postnatal day 3 with no signs of clinical and laboratory infection and are evaluated for hyperbilirubinemia will be referred to as the Control group.
The Control group wll consist term infants with the same gestational and postnatal age of the infants that will be included in the study group.
In both groups, maternal samples will be obtained at the postpartum period at the time of infant's hospitalization.
Plasmas after separated and stored at -800C.
Levels of 25-OHD were determined using Shimadzu LC-20AT model High Performance Liquid Chromatography (HPLC) system.
Data will be analyzed using SPSS software and appropriate statistical analyses will be performed.
Study Type
Observational
Enrollment (Actual)
50
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Istanbul, Turkey
- Kanuni Sultan Suleyman Training and Research Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
No older than 3 days (Child)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Infants admitted to neonatal care unit with the diagnosis of high probable sepsis will constitute the sepsis group, whereas infants admitted to outpatient clinic without findings of sepsis will constitute the control group
Description
Inclusion Criteria:
- Infants >37 weeks of gestational age and are admitted to Neonatal Care Unit of Kanuni Sultan Suleyman Training and Research Hospital
- Infants with clinical and laboratory findings of early neonatal sepsis
- Term infants without sepsis as the control group
Exclusion Criteria:
- presence of maternal clinical and/or histological chorioamnionitis,
- presence of premature rupture of membranes (PROM),
- infants with probable or possible sepsis according to criteria,
- refusal of parental consent,
- lack of laboratory data,
- major congenital abnormalities
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
sepsis group, control group
Sepsis group; infants with the diagnosis of high probable sepsis Control group; infants without sepsis
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
development of early onset sepsis
Time Frame: 1 year
|
A total of 100 infants will be included and vitamin D levels will be compared between those with and without neonatal sepsis
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
severity of vitamin D deficiency and neonatal sepsis
Time Frame: one year
|
Infants will be divided into three groups in terms of mild, moderate and severe vitamin D deficiency according to maternal and neonatal vitamin D levels and a possible association between vitamin D deficiency and culture proven sepsis will be investigated.
|
one year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Karatekin G, Kaya A, Salihoglu O, Balci H, Nuhoglu A. Association of subclinical vitamin D deficiency in newborns with acute lower respiratory infection and their mothers. Eur J Clin Nutr. 2009 Apr;63(4):473-7. doi: 10.1038/sj.ejcn.1602960. Epub 2007 Nov 21.
- Gitto E, Karbownik M, Reiter RJ, Tan DX, Cuzzocrea S, Chiurazzi P, Cordaro S, Corona G, Trimarchi G, Barberi I. Effects of melatonin treatment in septic newborns. Pediatr Res. 2001 Dec;50(6):756-60. doi: 10.1203/00006450-200112000-00021.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2012
Primary Completion (Actual)
January 1, 2013
Study Completion (Actual)
January 1, 2013
Study Registration Dates
First Submitted
December 18, 2013
First Submitted That Met QC Criteria
December 18, 2013
First Posted (Estimate)
December 24, 2013
Study Record Updates
Last Update Posted (Estimate)
December 30, 2013
Last Update Submitted That Met QC Criteria
December 26, 2013
Last Verified
December 1, 2013
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MC10000
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vitamin D Deficiency
-
University Hospital, Clermont-FerrandTerminated
-
Federal University of Rio Grande do SulCompletedDeficiency, Vitamin DBrazil
-
Rajavithi HospitalQueen Sirikit National Institute of Child HealthCompleted
-
Universidade de Passo FundoUnknownDeficiency, Vitamin DBrazil
-
Nutrition Institute, SloveniaEuropean Regional Development Fund; Vizera d.o.o.; Frutarom Etol d.o.o.CompletedVitamin B 12 Deficiency | Vitamin d Deficiency | Protein DeficiencySlovenia
-
Wageningen UniversityDSM Nutritional Products, Inc.; Top Institute Food and NutritionCompletedElderly, Frail | Deficiency, Vitamin DNetherlands
-
University of PaviaIstituti Clinici Scientifici Maugeri SpAUnknownVitamin D Deficiency | Vitamin D3 Deficiency | Vitamin DItaly
-
Okan UniversityArçelik A.Ş.Completed
-
Brigham and Women's HospitalCompletedVitamin d Deficiency
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNot yet recruitingVitamin d DeficiencyChina
Clinical Trials on Determining maternal and neonatal vitamin D levels
-
Hannah Brown AmoakohUniversity of Ghana; Ghana Health ServicesCompletedEclampsia | Asphyxia | Neonatal Jaundice | Postpartum Haemorrhage | Pre-eclampsia | Maternal Death | Neonatal Sepsis | Neonatal Death | Pregnancy Induced Hypertension | Puerperal SepsisGhana
-
Aga Khan UniversityThe International Federation of Red Cross and Red Crescent SocietiesCompletedPneumonia | Anemia | Eclampsia | Postpartum Hemorrhage | Diarrhoea | Neonatal Sepsis | Birth Asphyxia | Antepartum Hemorrhage
-
University Hospital, MontpellierCompletedUterine Rupture | Mode of DeliveryFrance
-
Cairo UniversityCompletedUmbilical Cord ClampingEgypt
-
Inonu UniversityCompletedEducation | Mobile Messages | Breastfeeding Self-efficacy | Breastfeeding Attitude | Maternal Experience SatisfactionTurkey
-
Children's Hospital of Fudan UniversityMinhang Maternal and Children Health Care HospitalCompletedAtopic DermatitisChina
-
University Hospital, MontpellierActive, not recruitingTwin Pregnancy With Antenatal Problem | Pregnant With ComplicationFrance
-
Göteborg UniversityNorwegian Institute of Public Health; Sahlgrenska University Hospital, SwedenCompletedVitamin D Deficiency | Body Composition | Cardiometabolic Risk | Vascular HealthSweden
-
Hillel Yaffe Medical CenterUnknownVitamin D Deficiency | Hypocalcemia
-
Bursa City HospitalUnknown